Evidence map›Paper›PMID 35424642›Full record

ArticleRSC advances2022

Modeling the

Qi Xin, Jie Cheng, Hongwei Wang, Wenying Zhang, Hong Lu, Junpeng Zhou, Glenn V Lo, Yusheng Dou, Shuai Yuan

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 65% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Qi XinChongqing Key Laboratory of Big Data for Bio Intelligence, Chongqing University of Posts and Telecommunications Chongqing 40065 China zhangwenying@cqupt.edu.cn yuanshuai@cqupt.edu.cn.
Jie ChengChongqing Key Laboratory of Big Data for Bio Intelligence, Chongqing University of Posts and Telecommunications Chongqing 40065 China zhangwenying@cqupt.edu.cn yuanshuai@cqupt.edu.cn.
Hongwei WangSchool of Chemistry and Molecular Biosciences, The University of Queensland Brisbane St Lucia QLD 4072 Australia.
Wenying ZhangChongqing Key Laboratory of Big Data for Bio Intelligence, Chongqing University of Posts and Telecommunications Chongqing 40065 China zhangwenying@cqupt.edu.cn yuanshuai@cqupt.edu.cn.
Hong LuChongqing Key Laboratory of Big Data for Bio Intelligence, Chongqing University of Posts and Telecommunications Chongqing 40065 China zhangwenying@cqupt.edu.cn yuanshuai@cqupt.edu.cn.
Junpeng ZhouChongqing Key Laboratory of Big Data for Bio Intelligence, Chongqing University of Posts and Telecommunications Chongqing 40065 China zhangwenying@cqupt.edu.cn yuanshuai@cqupt.edu.cn.
Glenn V LoDepartment of Chemistry and Physical Sciences, Nicholls State University P.O. Box 2022 Thibodaux LA 70310 USA.
Yusheng DouDepartment of Chemistry and Physical Sciences, Nicholls State University P.O. Box 2022 Thibodaux LA 70310 USA.
Shuai YuanChongqing Key Laboratory of Big Data for Bio Intelligence, Chongqing University of Posts and Telecommunications Chongqing 40065 China zhangwenying@cqupt.edu.cn yuanshuai@cqupt.edu.cn.ORCID https://orcid.org/0000-0002-1760-9731
Chongqing University of Posts and Telecommunications · CNNicholls State University · USThe University of Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ion channel of channelrhodopsin-2 (ChR2) is activated by absorbing light. The light stimulates retinal to isomerize to start the photocycle. There are two pathways for photocycles, which are caused by isomerization of the retinal from all-

Identifiers

PMID35424642
PMCPMC8981705
OpenAlexW4213412858

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.